Ankylosing spondylitis (AS) is an autoimmune condition that causes inflammation in the spine, joints, and bones. Ankylosing spondylitis affects women more often than previously thought. In the past, ...

Bimekizumab demonstrated safety and efficacy at 2 years among patients with nonradiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS). Bimekizumab is currently FDA approved ...

NEW YORK (Reuters Health), Dec 28 - Ankylosing spondylitis increases the risk of periodontal disease, German researchers report in the January issue of Annals of the Rheumatic Diseases. Lead author Dr ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. There were no new safety signals, while all fungal ...

In this case, the patient does not have features fully consistent with a diagnosis of Crohn's disease. The presentation is more in keeping with a diagnosis of ileitis of spondylarthropathy. It can be ...

(UPDATED July 25, 2013) — A major observational study in ankylosing spondylitis (AS) published online July 1 in Arthritis & Rheumatism revealed that tumor necrosis factor (TNF) inhibitors ...

—Researchers in Canada compared isolated axial psoriatic arthritis, axial PsA with peripheral involvement, and isolated axial ankylosing spondylitis with psoriasis, to determine which factors predict ...

ATLANTA, Nov. 10, 2023 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new long-term data from the BIMZELX® (bimekizumab) Phase 2b study BE AGILE and its open-label extension ...

Ankylosing Spondylitis (AS) is the leading chronic progressive inflammatory rheumatic disease that involves the sacroiliac joints (SIJs) and the spinal column but is often difficult to recognize in ...